TWTR Stock DD Twitter, Inc. 08/04/2014 22:33:16

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
TWTR Twitter, Inc. $TWTR Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=TWTR&...mp;yt0=Go!

Last Updated: 08/04/2014 22:33:11

Current Price and Quotes
Last Price 43.47
Previous Close 44.13 Open 43.70
Daily Range 43.44 - 44.53 52wk Range 29.51 - 74.73
Volume 22,424,950 Dividend N/A
Average Vol (3m) 32,913,465 Yield N/A




Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 664,890 316,933 106,313
Cost of Revenue 266,718 128,768 61,803
Gross Profit 398,172 188,165 44,510
Operating Expenses

Research and Development 593,992 119,004 80,176
Sales, General and Admin. 440,011 146,244 91,745
Non-Recurring Items - - -
Other - - -
Operating Income (635,831) (77,083) (127,411)
Income From Continuing Operations

Add'l Income/Expense Items (4,455) 399 (1,530)
Earnings Before Interest and Tax (647,146) (79,170) (129,746)
Interest Expense - - -
Earnings Before Tax (647,146) (79,170) (129,746)
Income Tax (1,823) 229 (1,444)
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (645,323) (79,399) (128,302)
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (645,323) (79,399) (128,302)
Preferred Stock and Other Adjustments - - (35,816)
Net Income Applicable to Common Shareholders (645,323) (79,399) (164,118)

Recent News

TWTR Twitter, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=TWTR&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/TWTR/quote
Stock Chart http://www.otcmarkets.com/stock/TWTR/chart
Company Info http://www.otcmarkets.com/stock/TWTR/company-info
Recent News http://www.otcmarkets.com/stock/TWTR/news
Financials http://www.otcmarkets.com/stock/TWTR/financials
Filings and Disclosure http://www.otcmarkets.com/stock/TWTR/filings
Short Sales http://www.otcmarkets.com/stock/TWTR/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/TWTR/insider-transactions
Research Reports http://www.otcmarkets.com/stock/TWTR/research
Summary http://finance.yahoo.com/q?s=TWTR
Historical Prices http://finance.yahoo.com/q/hp?s=TWTR+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=TWTR
Basic Chart http://finance.yahoo.com/q/bc?s=TWTR+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=TWTR+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=TWTR+Headlines
Press Releases http://finance.yahoo.com/q/p?s=TWTR+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=TWTR+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=TWTR+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=TWTR+Industry
Major Holders http://finance.yahoo.com/q/mh?s=TWTR+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=TWTR+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=TWTR+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=TWTR
Balance Sheet http://finance.yahoo.com/q/bs?s=TWTR
Cash Flow http://finance.yahoo.com/q/cf?s=TWTR+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/TWTR
Market Watch http://www.marketwatch.com/investing/stock/TWTR
Bloomberg http://www.bloomberg.com/quote/TWTR:US
Morningstar http://quotes.morningstar.com/stock/s?t=TWTR
Bussinessweek http://investing.businessweek.com/research/st...icker=TWTR
Barchart http://www.barchart.com/quotes/stocks/TWTR
OTC Short Report http://otcshortreport.com/index.php?index=TWTR
Investopedia http://www.investopedia.com/markets/stocks/TWTR/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading